QuickLogic Corp (NASDAQ: QUIK) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.02 versus $0.15 for the same period a year ago — a decline of -113%. For the latest […]
Planet Fitness Inc (NYSE: PLNT) has reported E.P.S. of $0.56 for its fourth fiscal quarter (ending December 31) versus $0.41 for the same period a year ago — an increase of 37%. E.P.S. were $2.01 […]
For its fourth fiscal quarter (ending December 31), Matson Inc (NYSE: MATX) has reported a 115% increase in E.P.S. from $1.80 a year ago to $3.87 in the current quarter. E.P.S. were $14.14 for the […]
MGE Energy Inc (NASDAQ: MGEE) has reported E.P.S. of $0.61 for its fourth fiscal quarter (ending December 31) versus $0.55 for the same period a year ago — an increase of 11%. For the latest […]
Integra LifeSciences Holdings Co (NASDAQ: IART) has reported E.P.S. of $0.25 for its fourth fiscal quarter (ending December 31) versus $0.26 for the same period a year ago — a decline of -4%. For the […]
Inogen Inc (NASDAQ: INGN) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.41 versus a loss $-1.14 for the same period a year ago — a decline of -64%. For […]
HENRY SCHEIN INC (NASDAQ: HSIC) has reported E.P.S. of $0.75 for its fourth fiscal quarter (ending December 31) versus $0.13 for the same period a year ago — an increase of 477%. For the latest […]
For its fourth fiscal quarter (ending December 31), Global Industrial Co (NYSE: GIC) has reported a -32% decline in E.P.S. from $0.40 a year ago to $0.27 in the current quarter. E.P.S. were $1.58 for […]
Extremely important negative changes in investment behavior have recently occurred for Artivion Inc (NYSE: AORT): the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, the stock fell […]
On 2/25/25, iBio Inc (NYSEAMERICAN: IBIO) stock enjoyed a major increase of 13.1%, closing at $3.89. Moreover, trading volume in this advance was exceptionally high at 759% of normal. The stock has risen 13.4% during […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research